Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments
Investors are noticing ripe opportunity in Cytokinetics, a late-stage biopharma company targeting medicines for specialty heart diseases, that has seen ...
Saturday, January 31, 2026
Tag: Cytokinetics
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.